| Study Protocol Number | Study Title and Description |
|---|---|
| 26-1801 |
A Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease (ROUSSEAU)
The study is testing whether an RSV vaccine is safe and helps protect children ages 5 to 17 who have a higher chance of getting very sick from RSV. |